Literature DB >> 8533465

Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides.

M Ochoa1, J Bárcena, S de la Luna, J A Melero, A R Douglas, A Nieto, J Ortín, J J Skehel, A Portela.   

Abstract

Characterization of the epitopes recognized by 21 monoclonal antibodies (MAbs) specific for the influenza A virus PA (13 MAbs) and PB2 (8 MAbs) polypeptides (Bárcena et al. (1994) J. Virol. 68, 6900-6909) raised against denatured polypeptides produced in E. coli is described. MAbs were characterized by: (1) competitive binding ELISAs; (2) mapping of the protein regions that specify their binding sites; and (3) analyses of their ability to recognize the corresponding viral protein in a number of viral isolates. Five and three non-overlapping antigenic areas were defined by the anti-PA and anti-PB2 MAbs, respectively. Five of the anti-PA MAbs recognized antigenic determinants located within the amino-terminal 157 amino acids of the PA protein, and 6 others reacted strongly with a PA fragment comprising the first 236 amino acids. All 8 anti-PB2 antibodies reacted strongly with a polypeptide fragment containing amino acids 1-113 of the PB2 protein. Analyses of the reactivities of 4 anti-P antibodies with 23 influenza A virus reference strains isolated over a period of 61 years and recovered from humans, pigs, birds and horses, showed that the epitopes were conserved among all viral isolates. The application of these antibodies as research and diagnostic tools is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533465     DOI: 10.1016/0168-1702(95)00039-s

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

1.  Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription.

Authors:  Pablo Gastaminza; Beatriz Perales; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Replication-competent influenza A virus that encodes a split-green fluorescent protein-tagged PB2 polymerase subunit allows live-cell imaging of the virus life cycle.

Authors:  Sergiy V Avilov; Dorothée Moisy; Sandie Munier; Oliver Schraidt; Nadia Naffakh; Stephen Cusack
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Structural and functional characterization of an influenza virus RNA polymerase-genomic RNA complex.

Authors:  Patricia Resa-Infante; María Angeles Recuero-Checa; Noelia Zamarreño; Oscar Llorca; Juan Ortín
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.

Authors:  Susana de Lucas; Joan Peredo; Rosa María Marión; Carmen Sánchez; Juan Ortín
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein.

Authors:  Chien-Hung Liu; Ligang Zhou; Guifang Chen; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

6.  Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit.

Authors:  B Perales; S de la Luna; I Palacios; J Ortín
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants.

Authors:  J Joukje Siebenga; Philippe Lemey; Sergei L Kosakovsky Pond; Andrew Rambaut; Harry Vennema; Marion Koopmans
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

8.  Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein.

Authors:  Guifang Chen; Chien-Hung Liu; Ligang Zhou; Robert M Krug
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

9.  Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.

Authors:  Kanako Sugiyama; Eiji Obayashi; Atsushi Kawaguchi; Yukari Suzuki; Jeremy R H Tame; Kyosuke Nagata; Sam-Yong Park
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

10.  Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication.

Authors:  Núria Jorba; Rocío Coloma; Juan Ortín
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.